Bifidobacterium breve Bif195 Protects Against Small-intesti…

A CCEPTED MANUSCRIPT

Bifidobacterium breve Bif195 Protects Against Small-intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers A randomized, placebo-controlled, double-blind clinical trial Aspirin + Bif195 Aspirin + Placebo Bif195 Placebo

Bif195 / Placebo

Aspirin

=35

= 31

Powered by